Aptose Biosciences and Hanmi Pharmaceutical Extend Loan Agreement for US$11.9 Million to Develop Tuspetinib for AML Treatment.
Sep 22, 2025
Contract Type
agreement
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearch
Description
Aptose Biosciences Inc. has entered into an amended US$11.9 million loan Facility Agreement with Hanmi Pharmaceutical Co. Ltd. to support the development of its tuspetinib-based therapy for acute myeloid leukemia
Company Information
Company
Aptose Biosciences
Location
12770 High Bluff Dr
San Diego, California, United States
About
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.